23andMe Holding Co. (ME)
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.
$153.73M
Ms. Anne Wojcicki
South San Francisco, CA
Jun 17, 2021
-0.23
$-1.31
2.64
3.03
-110.45%
-1.22
0.59
1.38
2.68
-37.51%
-44.16%
Similar stocks (9)
Thermo Fisher Scientific Inc.
TMO
Danaher Corporation
DHR
Agilent Technologies, Inc.
A
IDEXX Laboratories, Inc.
IDXX
Illumina, Inc.
ILMN
Waters Corporation
WAT
Guardant Health, Inc.
GH
Twist Bioscience Corporation
TWST
DermTech, Inc.
DMTK
ETF Exposure (18)
Invesco Nasdaq Biotechnology ETF
IBBQ
0.01%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.01%
Schwab U.S. Small-Cap ETF
SCHA
0.0036986083%
ProShares Ultra Nasdaq Biotechnology
BIB
0.002903678983720862%
Schwab U.S. Broad Market ETF
SCHB
4.780869e-4%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
2.9e-4%
Fidelity Nasdaq Composite Index ETF
ONEQ
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (9)
Thermo Fisher Scientific Inc.
TMO
Danaher Corporation
DHR
Agilent Technologies, Inc.
A
IDEXX Laboratories, Inc.
IDXX
Illumina, Inc.
ILMN
Waters Corporation
WAT
Guardant Health, Inc.
GH
Twist Bioscience Corporation
TWST
DermTech, Inc.
DMTK
ETF Exposure (18)
Invesco Nasdaq Biotechnology ETF
IBBQ
0.01%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.01%
Schwab U.S. Small-Cap ETF
SCHA
0.0036986083%
ProShares Ultra Nasdaq Biotechnology
BIB
0.002903678983720862%
Schwab U.S. Broad Market ETF
SCHB
4.780869e-4%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
2.9e-4%
Fidelity Nasdaq Composite Index ETF
ONEQ
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%